Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct.

about

Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.

P2860

Q55287570-0F614BF9-72FB-45FE-9ECC-B693DF9B3598

P2860

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct.

Item

http://www.wikidata.org/entity/Q38843274

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Maturation of human pluripoten ...... d in cardiovascular construct.

@en

type

Item

label

Maturation of human pluripoten ...... d in cardiovascular construct.

@en

prefLabel

Maturation of human pluripoten ...... d in cardiovascular construct.

@en

P1476

Maturation of human pluripoten ...... ed in cardiovascular construct

@en

P2093

Hanna Vuorenpää

http://www.w3.org/2001/XMLSchema#string

Jertta-Riina Sarkanen

http://www.w3.org/2001/XMLSchema#string

Katriina Aalto-Setälä

http://www.w3.org/2001/XMLSchema#string

Mari Pekkanen-Mattila

http://www.w3.org/2001/XMLSchema#string

Timo Ylikomi

http://www.w3.org/2001/XMLSchema#string

Tuula Heinonen

http://www.w3.org/2001/XMLSchema#string

P2860

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Cardiomyocyte MEA data analysis (CardioMDA)--a novel field potential data analysis software for pluripotent stem cell derived cardiomyocytes

Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues

Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes

Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Use and application of stem cells in toxicology.

P2888

s10616-017-0088-1

P304

785-800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10616-017-0088-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kirsi Penttinen

P577

2017-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084744402

http://www.w3.org/2001/XMLSchema#string

P698

28397099

http://www.w3.org/2001/XMLSchema#string

P932

5595750

http://www.w3.org/2001/XMLSchema#string

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct.

about

P2860

P2860

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932